Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives-Reference-Cited by-同舟云学术

Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives

Published:2019-11 Issue: Volume:181 Page:111559
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhang Bing,Dai Xiwen,Bao Ziyang,Mao Qing,Duan Yulin,Yang Yuwei,Wang Shaojie^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference66 articles.

1. Inhibitors of xanthine oxidase: scaffold diversity and structure-based drug design;Luna;ChemMedChem,2019

2. The treatment of hyperuricemia;Gliozzi;Int. J. Cardiol.,2016

3. An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015);Ojha;Expert Opin. Ther. Pat.,2017

4. Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview;Chen;Med. Sci. Monit.,2016

5. Screening of a library of 4-aryl/heteroaryl-4H-fused pyrans for xanthine oxidase inhibition: synthesis, biological evaluation and docking studies;Kaur;Med. Chem. Res.,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors;European Journal of Medicinal Chemistry;2024-05

2. Recent developments in synthetic strategies and pharmacological outcomes of synthetic xanthine oxidase inhibitors: A comprehensive review;Journal of Heterocyclic Chemistry;2024-03-05

3. Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure–activity relationship and molecular docking studies (2018–2024);RSC Medicinal Chemistry;2024

4. Exploration of novel non-purine xanthine oxidase inhibitors based on oxadiazolones by an integrated simulation study;New Journal of Chemistry;2024

5. Agents for the Treatment of Gout: Current Advances and Future Perspectives;Journal of Medicinal Chemistry;2023-11-01